About OXYZ
At OXYZ, we are at the forefront of innovative healthcare, dedicated to transforming lives through cutting-edge cell therapy treatments. Our commitment to excellence, scientific advancement, and patient well-being sets us apart as a leader in the field.
Empowering Health, Transforming Lives.
OXYZ is driven by a mission to harness the incredible potential of cell therapy to revolutionize healthcare. We strive to bring hope and healing to patients through personalized and effective treatments that address a wide range of medical conditions.
MEGA+
Powerful with cell peptides, proteins, and factors to regenerate organs and tissues & support in physiological pro-cess. For overall vital organ support. Best for overall prevention and health maintenance. Ideal for short term and immediate boost. German Approach
MACRO
Good for regulating and restoring physiological functions and cell structures focus on the continuous delivery of cellular molecular information to achieve cellular self-healing function. Contains cell peptides and proteins for mid to long term chronic disease management. German Approach Cell Power
MICRO CELL
Consist of cell peptides for organ specific nourishment and works especially well on connective tissue stimulation and revitalization replenishment. Topically used on affected joints, skin tightening and wrinkle treatment. It also has a wide range of applications for mild diseases. Suitable for long term treatment. German Approach
Stem Cell Dynamic Therapy
At OXYZ, we steadfastly adhere to the principle of stem cell therapy known as “like treats like.” Recognizing that cell therapy is not a one-size-fits-all solution, we emphasize its tailored nature. Our approach involves meticulous selection, adaptation, and precise targeting, ensuring that cell therapy serves as a specialized and individualized treatment designed to support specific organs. This commiment to customization ensures that each therapy is carefully crafted to address the unique needs of every individual, reflecting our dedication to providing targeted and effective organ support.
This personalized strategy enhances therapeutic outcomes, maximizing the regenerative potential of stem cell therapy.
By prioritizing precision and adaptability, we empower individuals with treatments that align seamlessly with their unique health needs.
HISTORY
Ancient Roots and Early Concepts
The idea of organ extract cell therapy dates back thousands of years. As early as 1600 B.C., ancient writings recommended injecting extracts from animal organs to enhance human vitality. Later, in the 16th century, Swiss physician Paracelsus introduced the foundational theory of “like heals like,” stating that the heart heals the heart, the lung heals the lung, and the spleen heals the spleen. This principle remains influential in modern cellular therapy.
Early Scientific Discoveries
The 19th century saw groundbreaking advancements in understanding living cells. French Nobel laureate Dr. Alexis Carrel conducted a remarkable experiment, keeping chicken heart cells alive for 25 years after the bird’s death, proving that cells could potentially be immortal. Around the same time, Dr. Charles-Edward Brown-Séquard experimented with animal testicle extracts to combat aging effects, leading to what became known as the Brown-Séquard Elixir.
The Rise of Cellular Therapies
In the 1920s, Russian ophthalmologist Vladimir Filatov pioneered extract therapies to rejuvenate chronically ill patients, achieving success in treating retinal degeneration. Then, in 1931, Swiss physician Dr. Paul Niehans revolutionized cell therapy when he saved a woman’s life using calf parathyroid cells. Over time, he treated over 50,000 patients, including famous figures like Charlie Chaplin and Winston Churchill. In 1953, Pope Pius XII invited him to join the Pontifical Academy of Sciences, marking a major milestone in Western cellular therapy.
1885 - 1971
Dr. Med. Vet. Josef Miller
Deutsch-Französischen Gesellschaft für Thymus Therapie (DFGTT) is a registered society, founded in Germany with founders of Dr Miller and Dr Sandberg discovered the major importance of the thymus gland in immunological maturation since 1961. Its board members are scientifically qualified persons who provide treatment with thymus and cell factors, and support cel therapy in word and print, and affirm the aim of this association.
Deutsch-Französischen Gesellschaft für Thymus Therapie (DFGTT) with a mission to make thymus and cell factors better known among medical therapists and patients by explaining their positive health effects.